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Background: The consumption of green leafy vegetables (GLVs) has been demonstrated to reduce the risks
associated with cardiovascular and other diseases. However, no literature exists that examines the influence of
traditional and novel GLVs on the liver fatty acid profile of an animal model genetically predisposed to developing
hypertension. The aim of the present study was to examine the effects of diets containing 4% collard greens,
purslane or sweet potato greens on the liver fatty acid profiles of four-week old male spontaneously hypertensive
rats (SHRs, N = 44). Following four weeks consumption of the diets, liver fatty acid profiles were determined by gas–
liquid chromatography of transesterified fatty acid methyl esters.
Results: SHRs consuming the control diet had greater percentages of liver saturated fatty acid and less omega-3
fatty acid percentages. SHRs consuming the diets containing vegetables had significantly greater liver concentra-
tions of γ- linolenic, docosahexaenoic and docosahexaenoic acids, as well as lower levels of lauric, palmitic and ara-
chidonic acids. SHRs consuming the control diet had significantly greater percentages (p < 0.05) of oleic;
significantly less γ-linolenic and docosahexaenoic acids.
Conclusions: This study demonstrates the ability of GLVs to modulate liver fatty acid composition, thus providing
protection against elevations in atherogenic fatty acids, which may be involved in CVD pathogenesis. Consequently,
dietary recommendations for the prevention of CVD should consider the possible cardioprotective benefits and the
subsequent alterations in fatty acid profiles afforded by diets containing collard greens, purslane and sweet potato
greens.Background
Cardiovascular disease (CVD) is the leading cause of
morbidity and mortality in the US as well as developing
nations [1]. In addition to genetic predisposition, risk
factors for CVD include atherogenic dietary patterns af-
fluent in processed food products, total fat, saturated fat,
cholesterol, refined carbohydrates and sodium and inad-
equate intakes of whole grain products, fruits, vegetables
and dietary fiber [2-5].
Plants, particularly green leafy vegetables (GLVs), serve
as a major dietary reservoir of the essential PUFAs, dietary
fiber, antioxidants and other bioactive compounds that
exert cardioprotective and chemopreventive biological* Correspondence: krw0018@auburn.edu
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reproduction in any medium, provided the ormechanisms [6-9]. Epidemiological studies have revealed
that consumption of fruits and vegetables may be inversely
associated with risk for CVD and certain cancers, with the
prevalence of disease much lower among individuals con-
suming near or above the recommended servings com-
pared to those consuming fewer than the recommended
intakes [10-12].
Collard greens (Brassica oleracea), a traditional GLV
consumed mainly in the southern region of the United
States, in addition to purslane (Portulaca oleracea) and
sweet potato greens (Ipomoea batatas L.), novel GLVs to
the typical American diet, may prove beneficial in redu-
cing the risks associated with CVD development and pro-
gression [13-17]. Research has demonstrated reductions in
CVD risk following consumption of these green leafy
vegetables, both in vivo and in vitro [18-22]. Although
epidemiological evidence has affirmed the associationl Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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there is limited research examining the effects of diets
containing collard greens (CG), purslane (PL) and sweet
potato greens (SPG) on cardiovascular disease risk, namely
liver fatty acid profiles. To test the hypothesis that diets
containing CG, PL and SPG (4% dry weight) will contrib-
ute to improvements in liver fatty acid profiles the present
study was designed to determine the effects of diets con-
taining these GLVs on the liver fatty acid profile of animals
genetically predisposed to developing hypertension, the
spontaneously hypertensive rat. This study will advance
human nutrition research with inferences made regarding
the effects of consumption of traditional and novel GLVs
on CVD risk factors. Additionally, further recommenda-
tions regarding supplementation of these GLVs into the
diet on CVD risk may be presented.
Results
Liver saturated fatty acids
Liver saturated fatty acid concentrations of SHRs consum-
ing the various diets are presented in Table 1. SHRs con-
suming the control diet had trace amounts of lauric acid
(C12:0) that was significantly (P < 0.05) greater than those
consuming the experimental diets. Significantly greater
amounts of pentadecanoic acid (C15:0) were present in
the livers of SHRs consuming PL diet (0.09 ± 0.01) in com-
parison to those consuming the SPG diet (0.06 ± 0.01).
Liver monounsaturated fatty acids
SHRs consuming diets containing CG, PL and SPG ex-
hibited significantly lower liver concentrations of palmi-
toleic (C16:1n7) acid (0.78 ± 0.19, 0.90 ± 0.14, 0.12 ±
0.02, respectively) than those consuming the controlTable 1 Liver saturated fatty acid concentrations of SHRs fed
Fatty acid Structure Control
Capric C10:0 nd
Undecylic C11:0 nd
Lauric C12:0 0.01 ± 0.00a
Tridecylic C13:0 1.60 ± 0.43a
Myristic C14:0 0.29 ± 0.04a
Pentadecanoic C15:0 0.07 ± 0.01ab
Palmitic C16:0 21.01 ± 0.70a
Heptadecanoic C17:0 0.27 ± 0.13a
Stearic C18:0 16.30 ± 0.71a
Arachidic C20:0 0.08 ± 0.04a
Behenic C22:0 0.11 ± 0.02a
Lignoceric C24:0 0.41 ± 0.16a
§Data are (expressed as) mean percentage ± SE. Values in the same row that do not
analysis of variance and Duncan’s post hoc procedures (P < .05); nd = not detected.
Control = AIN-76 A control diet; 4% CG = AIN-76A diet + 4% collard green powder; 4
sweet potato green powder.diet (1.42 ± 0.06). Liver oleic acid (C18:1n9) was signifi-
cantly increased following 4 weeks consumption of the
control diet (12.69 ± 1.03). Among SHRs consuming
diets containing GLVs, oleic acid concentration was
greater with consumption of the PL diet (7.70 ± 1.14),
followed by the CG (7.40 ± 1.95) and SPG (5.57 ± 1.16)
diets. A more than two-fold significant increase in eicose-
noic acid (C20:1n12) was present among SHRs assigned
to the PL dietary group (0.28 ± 0.00) in comparison to
those assigned to the control group (0.12 ± 0.03) (Table 2).
Liver polyunsaturated fatty acids
SHRs in the control group exhibited significantly lower
amounts of γ-linolenic (GLA, C18:3n6) and docosahex-
aenoic (DHA, C22:6n3) acids versus those consuming
the experimental diets containing GLVs (Table 3). GLA
percentages ranged from 0.93 ± 0.49 (control) to 5.59 ±
0.73 (PL); DHA percentages ranged from 5.16 ± 0.35
(control) to 8.53 ± 0.63 (SPG). Significantly less docosa-
trienoic acid (C22:3n3) was present following the con-
sumption of the PL diet (0.60 ± 0.11) versus the control
diet (1.01 ± 0.07). A significantly greater amount of doc-
osahexaenoic acid (C22:6n3) was present following the
consumption of the experimental diets containing CG
(8.31 ± 1.27), PL (8.44 ± 1.02) and SPG (8.53 ± 0.63) in
comparison to the control diet (5.16 ± 0.35).
Liver total fatty acids
Although not statistically significant, SHRs consuming
the control diet exhibited a greater percentage of liver
total saturated fatty acids [23] (39.68 ± 1.51) and a lesser
percentage of total unsaturated fatty acids (UFA; 62.18 ±
1.22) (Table 4). SHRs consuming the experimental dietsdiets for 4 weeks§
Dietary group
4% CG 4% PL 4% SPG
nd nd nd
nd nd nd
0.00 ± 0.00b 0.00 ± 0.00b 0.00 ± 0.00b
1.12 ± 0.25a 1.02 ± 0.39a 1.33 ± 0.30a
0.29 ± 0.06a 0.29 ± 0.05a 0.26 ± 0.06a
0.08 ± 0.01ab 0.09 ± 0.01a 0.06 ± 0.01b
18.44 ± 4.24a 19.47 ± 2.67a 16.95 ± 3.07a
0.64 ± 0.32a 0.78 ± 0.27 a 0.88 ± 0.38a
20.71 ± 4.60a 17.45 ± 2.53a 18.31 ± 2.53a
0.04 ± 0.00a nd 0.05 ± 0.00a
0.31 ± 0.08a 0.39 ± 0.15a 0.40 ± 0.09a
0.59 ± 0.24a 1.23 ± 1.05a 0.62 ± 0.38a
share the same superscript letter are significantly different according to
% purslane = AIN-76A diet + 4% purslane powder; 4% SPG = AIN-76A diet + 4%
Table 2 Liver monounsaturated fatty acid concentrations of SHRs fed diets for 4 weeks§
Dietary group
Fatty acid Structure Control 4% CG 4% PL 4% SPG
Pentadecenoic C15:1n5c 0.09 ± 0.02a 0.04 ± 0.00a 0.02 ± 0.00a 0.05 ± 0.00a
Palmitelaidic C16:1 t 0.18 ± 0.03a 0.14 ± 0.02a 0.15 ± 0.03a 0.12 ± 0.02a
Palmitoleic C16:1n7 1.42 ± 0.06a 0.78 ± 0.19b 0.90 ± 0.14b 0.74 ± 0.15b
Heptadecenoic C17:1n7 0.04 ± 0.01a 1.56 ± 1.53a 0.07 ± 0.03a 0.03 ± 0.01a
Cis-vaccenic C18:1n7c 3.36 ± 0.61a 2.05 ± 0.31a 2.20 ± 0.10a 2.33 ± 0.12a
Elaidic C18:1n9t 1.90 ± 0.21a 5.95 ± 4.11a 1.53 ± 1.43a 2.49 ± 2.45a
Oleic C18:1n9c 12.69 ± 1.03a 7.40 ± 1.95b 7.70 ± 1.14b 5.57 ± 1.16b
Trans-vaccenic C18:1n11 1.82 ± 0.00a 0.16 ± 0.09a 0.65 ± 0.41a 1.42 ± 0.00a
Eicosenoic C20:1n12 0.12 ± 0.03a 0.16 ± 0.01ab 0.28 ± 0.00b 0.16 ± 0.06ab
§Data are (expressed as) mean percentage ± SE. Values in the same row that do not share the same superscript letter are significantly different according to
analysis of variance and Duncan’s post hoc procedures (P < .05); nd = not detected.
Control = AIN-76 A control diet; 4% CG = AIN-76A diet + 4% collard green powder; 4% purslane = AIN-76A diet + 4% purslane powder; 4% SPG = AIN-76A diet + 4%
sweet potato green powder.
Values in rows with multiple superscript letters (e.g. ab) are not significantly different from other values containing the shared superscript letter (e.g. a or b).
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centages of omega-3 fatty acids (7.88 ± 1.16, 7.67 ± 1.38,
8.62 ± 0.64, respectively) in comparison to those con-
suming the control diet (5.27 ± 0.34). Omega-3 fatty acid
percentages, as well as EPA +DHA percentages were
significantly greater following consumption of the SPG
diet than the control diet.
Discussion
Green leafy vegetables such as collard greens, traditionally
consumed in the southern region of the US, purslane andTable 3 Liver polyunsaturated fatty acid concentrations of SH
Fatty acid Structure Control
Linolelaidic C18:2n6t 0.49 ± 0.19a
Linoleic C18:2n6c 14.07 ± 0.68a
α-Linolenic C18:3n3 0.10 ± 0.01a
γ-Linolenic C18:3n6 0.93 ± 0.49a
Eicosadienoic C20:2n6 0.34 ± 0.04a
Eicosatrienoic C20:3n3 0.09 ± 0.02a
Dihomo-γ-linolenic C20:3n6 0.32 ± 0.02a
Arachidonic C20:4n6 20.39 ± 1.27a
Eicosapentaenoic C20:5n3 0.10 ± 0.02a
Docosadienoic C22:2n6 0.03 ± 0.02a
Docosatrienoic C22:3n3 1.01 ± 0.07a
Docosatatraenoic C22:4n6 0.68 ± 0.04a
Docosapentaenoic C22:5n3 1.95 ± 0.42a
Docosahexaenoic C22:6n3 5.16 ± 0.35a
§Data are (expressed as) mean percentage ± SE. Values in the same row that do not
analysis of variance and Duncan’s post hoc procedures (P < .05); nd = not detected.
powder; 4% purslane = AIN-76A diet + 4% purslane powder; 4% SPG = AIN-76A diet
Values in rows with multiple superscript letters (e.g. ab) are not significantly differensweet potato greens, relatively novel in the American diet,
which are rich sources of antioxidants, MUFA, PUFAs
and n-3 series PUFAs have demonstrated the ability to
attenuate the risks associated with disease pathogenesis
[24-29]. In the present study experimental diets con-
taining these GLVs were able to contribute to increased
SHR liver concentrations of cardio-protective omega-3
polyunsaturated fatty acids compared to the control
diet. Medeiros et al. demonstrated the ability of diets
enriched with the omega-3 fatty acid ALA to significantly
increase the omega-3 fatty acid (i.e. DHA) content of theRs fed diets for 4 weeks§
Dietary group
4% CG 4% PL 4% SPG
0.09 ± 0.01a 0.17 ± 0.05a 0.32 ± 0.27a
16.44 ± 0.01a 16.45 ± 2.78a 16.56 ± 2.82a
0.10 ± 0.02a 0.10 ± 0.01a 0.07 ± 0.02a
3.70 ± 0.18b 5.59 ± 0.73b 3.55 ± 1.20b
0.27 ± 0.06a 0.39 ± 0.09a 0.23 ± 0.04a
0.27 ± 0.14a 0.18 ± 0.10a 0.26 ± 0.15a
0.31 ± 0.04a 0.44 ± 0.03b 0.37 ± 0.02ab
14.15 ± 3.44a 15.80 ± 3.16a 18.51 ± 3.58a
0.10 ± 0.01a 0.19 ± 0.06a 0.10 ± 0.01a
4.09 ± 4.04a 0.09 ± 0.04a 0.07 ± 0.04a
0.76 ± 0.09ab 0.60 ± 0.11b 0.87 ± 0.11ab
0.64 ± 0.08a 0.78 ± 0.11a 0.85 ± 0.10a
2.98 ± 0.73a 2.34 ± 0.34a 1.72 ± 0.19a
8.31 ± 1.27b 8.44 ± 1.02b 8.53 ± 0.63b
share the same superscript letter are significantly different according to
Control = AIN-76 A control diet; 4% CG = AIN-76A diet + 4% collard green
+ 4% sweet potato green powder.
t from other values containing the shared superscript letter (e.g. a or b).
Table 4 Total liver fatty acid concentrations and ratios of SHRs fed diets for 4 weeks§
Dietary group
Fatty acid Control 4% CG 4% PL 4% SPG
Saturated 39.68 ± 1.51a 33.99 ± 7.63a 32.57 ± 5.91a 33.16 ± 5.64a
Unsaturated 62.18 ± 1.22a 67.64 ± 7.52a 67.84 ± 5.81a 68.97 ± 5.03a
Monounsaturated 18.25 ± 1.51a 20.22 ± 4.58a 22.14 ± 5.09a 20.17 ± 4.43a
Polyunsaturated 43.92 ± 1.51a 47.42 ± 6.27a 45.70 ± 1.89a 48.80 ± 1.04a
Omega-3 fatty acids 5.27 ± 0.34a 7.88 ± 1.16ab 7.67 ± 1.38ab 8.62 ± 0.64b
Omega-6 fatty acids 34.47 ± 1.47a 32.25 ± 2.15a 30.59 ± 3.06a 35.07 ± 1.05a
Omega-6/3 ratio 6.68 ± 0.23a 9.05 ± 4.97a 8.17 ± 4.87a 4.31 ± 0.33a
LA/ALA ratio 14.13 ± 1.51a 11.95 ±1.89a 12.17 ± 1.89a 17.48 ± 3.44a
EPA + DHA 5.20 ± 0.34a 7.82 ± 1.17ab 7.62 ± 1.38ab 8.59 ± 0.65b
§Data are (expressed as) mean percentage ± SE. Values in the same row that do not share the same superscript letter are significantly different according to
analysis of variance and Duncan’s post hoc procedures (P < .05); nd = not detected. Control = AIN-76 A control diet; 4% CG = AIN-76A diet + 4% collard green
powder; 4% purslane = AIN-76A diet + 4% purslane powder; 4% SPG = AIN-76A diet + 4% sweet potato green powder.
Saturated = sum of saturated fatty acids; unsaturated = sum monounsaturated fatty acids + sum polyunsaturated fatty acids); monounsaturated = sum of
monounsaturated fatty acids; polyunsaturated = sum of polyunsaturated fatty acids; omega-3 fatty acids = sum of C18:3n3, C20:5n3 and C22:5n3; omega-6 fatty
acids = sum of C18:2n6 and C20:4n6; omega-6/3 ratio = omega-6/omega-3 fatty acids; LA/ALA ratio = C18:2n6 (linoleic acid, LA)/C18:3n3 (α-linolenic acid, ALA); EPA
+ DHA = sum of C20:5n3 (eicosapentaenoic acid, EPA) and C22:6n3 (docosahexaenoic acid, DHA).
Values in rows with multiple superscript letters (e.g. ab) are not significantly different from other values containing the shared superscript letter (e.g. a or b).
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similar among SHRs consuming the different diets in the
present study, greater percentages of DHA were observed
among those consuming the diets containing the GLVs;
SHRs consuming the PL diet exhibited a greater percent-
age of EPA compared to those in the other dietary groups.
Interestingly, although ALA content was slightly less in
the livers of SHRs consuming the SPG diet, DHA content
was greater in comparison to those consuming the other
diets. Greater percentages of omega-3 fatty acids within
the livers of SHRs consuming diets containing GLVs,
particularly EPA and DHA, suggest potential cardiopro-
tection and reduced disease risk as demonstrated by
others [31].
Greater concentrations of omega-3 PUFAs compared
to omega-6 PUFAs among SHRs consuming diets con-
taining the GLVs implies that omega-6 PUFAs may be
metabolized to a lesser extent due to the competitive
nature of these PUFAs for participation in metabolic
pathways. In the current study liver ALA concentrations
were similar across all dietary groups, whereas LA con-
centrations were greater following consumption of the
experimental diets containing CG, PL and SPG; liver AA
concentrations were increased following consumption of
the control diet. The shift towards a trajectory favoring
the metabolism of ALA to a greater degree than LA,
suggest the ability of diets containing GLVs to promote
health and prevent disease.
The data generated from the present study examining
the liver fatty acid composition of SHRs consuming diets
containing traditional and novel GLVs indicate signifi-
cant differences in key atherogenic as well as cardiopro-
tective fatty acids. Research has shown an increased riskfor CVD with increasing concentrations of the saturated
fatty acids lauric, myristic and palmitic, which are consid-
ered to be more atherogenic [32]. In the present study,
SHRs consuming the control diet demonstrated greater
liver concentrations of both lauric and myristic acids. Fur-
ther, higher percentages of cardioprotective fatty acids of
the omega-3 series were found in the livers of SHRs fed
diets containing GLVs. The presence of higher levels of
these fatty acids suggest potential decreased disease risk via
the cardioprotective mechanisms of omega-3 fatty acids
generated during anti-inflammatory pathways present dur-
ing cardiovascular and other disease pathogenesis.
Conclusions
To our knowledge, this is the first study to examine the
effects of diets containing traditional (i.e. collard greens)
and novel (i.e. purslane and sweet potato greens) green
leafy vegetables on the liver fatty acid profile of the
spontaneously hypertensive rat. The current research
findings are in agreement with epidemiological evidence,
which suggests the cardioprotective and chemopreven-
tive advantages of consuming diets containing dark
green leafy vegetables. The results of this research sug-
gest the ability of diets containing collard greens, purs-
lane and sweet potato greens to favourable shift SHR
liver fatty acid compositions in such a way that may be
beneficial in reducing CVD risk in spontaneously hyper-
tensive rats.
The chief limitation of the current study was the dur-
ation of feeding of the control and experimental diets to
the spontaneously hypertensive rats. As CVD is a chronic,
inflammatory disease occurring over the course of the life-
span, extending the duration of feeding may offer critical
Table 5 Ingredient composition of control and experimental
diets fed to SHRs for 4 weeks
Dietary group
Ingredient (g/kg) Control 4% CG 4% PL 4% SPG
Sucrose 50.0 50.0 48.0 47.0
Casein 20.0 20.0 19.0 19.0
Corn starch 15.0 15.0 15.0 15.0
Powdered cellulose 5.0 2.0 4.0 5.0
Corn oil 5.0 5.0 5.0 5.0
AIN-76 mineral mix 3.5 4.0 4.0 4.0
AIN-76 vitamin mix 1.0 1.0 1.0 1.0
DL-methionine 0.3 0.3 0.3 0.3
Choline bitartrate 0.2 0.2 0.2 0.2
Collard greens - 4.0 - -
Purslane - - 4.0 -
Sweet potato greens - - - 4.0
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traditional GLVs on the pathogenesis of CVD. In addition,
focusing on only one aspect of CVD risk, namely the liver
fatty acid profile, fails to offer a comprehensive view of the
larger spectrum involved in CVD pathogenesis. Examining
the effects of diets containing collard greens, purslane and
sweet potato greens on factors such as the complete lipid
profile, lipid and other nutrient metabolism and other
relevant indices of cardiovascular health, such as cardiac
hypertrophy, inflammatory biomarkers, tissue morph-
ology, gene expression and SHR physiology, may offer
critical evidence regarding the influence of these diets on
disease outcomes. Further, implications and translation of
the current and future studies to human nutrition and car-
diovascular outcomes needs to be explored as well.
In addition, future research studies may want to con-
sider the isolation of nutrient and bioactive compounds
within these diets that may have contributed to the
presence of a beneficial fatty acid profile. Accordingly,
moderate to long-term feeding studies involving the
consumption of these diets by SHRs, as well as the con-
sumption of these diets by “normal” rats, not genetically
predisposed to developing hypertension warrant further
consideration. Therefore, confirming the relationship
between shifts in liver fatty acid profile on indices of car-
diovascular health or CVD disease pathogenesis, through
continued research studies will add credence to the
physiological relevance of the current research study.
Methods
Animals and diets
Forty-four (N = 44) male spontaneously hypertensive
rats (SHRs), approximately 4 weeks of age and weighing
100 grams were obtained from Charles River laborator-
ies (St. Louis, MO). The animals were housed individu-
ally in stainless steel cages at the animal care wing of
the Tuskegee University Comparative Medicine Re-
search Center. Room temperature and relative humidity
were maintained between 68 and 72°C and 55%, respect-
ively. SHRs were maintained on a 12-hour light/12-hour
dark cycle.
Experimental diets (Table 5), formulated according to
the American Institute of Nutrition (AIN) standards
were isocaloric and isonitrogenous, and manufactured
by the TestDiet® division of the Purina Mills Company
(Richmond, IN). Collard greens (CG) and purslane (PL)
were purchased from local farmers markets and sweet
potato greens (SPG) were grown on the campus of
Tuskegee University. Vegetables were washed, blotted
dry and frozen for at least 24 hours prior to freeze dry-
ing for approximately 48 hours (Virtis Genesis 25SL
freeze-dryer; Virtis Company, Gardiner, NY); following
freeze-drying, the samples were ground to pass through
a 60-mesh sieve. GLV powders were stored in an airtight container and shipped to the Purina Mills Com-
pany for incorporation into the experimental diets. Fol-
lowing subjection to a one week acclimation period,
SHRs were randomly assigned to one of four dietary
groups (n = 11 per dietary group): AIN-76A purified diet
(control), AIN-76A diet containing 4% collard greens
(CG; 4% dry weight), AIN-76A diet containing 4% purs-
lane (PL; 4% dry weight) or AIN-76A diet containing 4%
sweet potato greens (SPG; 4% dry weight).
Animals were pair fed based on the previous day’s
dietary intake of the control group and allowed to con-
sume food and water ad libitum. Following the 4-week
feeding experiment, animals were fasted overnight and
anaesthetized by overinhalation of carbon dioxide,
followed by cardiac puncture. SHR livers were removed
and stored at −80°C prior to analysis. The procedures in-
volved in the care and use of animals in this research
were approved by the Tuskegee University Institutional
Animal Care and Use Committee.
Liver fatty acid analysis
The extraction of total liver fatty acids was conducted
using the method of Folch et al. [33]. Briefly, thawed liver
tissue samples (~1 g) were homogenized in a chloroform-
methanol (2:1 vol/vol) mixture under nitrogen in an ice
bath and total lipids extracted. The homogenate was fil-
tered through Whatman No. 4 filter paper and 0.1 M
NaCl solution (4:1 ratio) was added to the filtered sample
solution. The sample was then flushed with nitrogen,
vortexed for 3 minutes and centrifuged at 2,000 rpm for
5 minutes. The organic layer was collected and dried off
using a nitrogen evaporator. Extracted total lipids were
then transferred into glass tubes and transmethylated by
subjection to 1 ml of boron trifluoride (12% in methanol;
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on a dry heating block at 110 to 115°C for 30 minutes to
produce fatty acid methyl esters (FAMEs). The tube was
then placed into an ice bath for 5 minutes; 2.0 ml of pent-
ane and 1.0 ml of deionized water was added, the sample
was flushed with nitrogen and vortexed for 15 seconds.
Following centrifugation for 5 minutes at 2,000 rpm the
top layer of the sample was collected and transferred into
a pre-weighed 13×100 Pyrex culture tube. Dichlorometh-
ane (DCM) was added (3 mL) and the sample was dried
using a nitrogen evaporator. Prior to gas chromatography
injection, the sample was resuspended in 200 μl of DCM.
Fatty acid methyl esters were isolated and quantified
by gas chromatography using a Hewlett-Packard 6890
gas chromatograph containing a fused silica capillary
column (DB-23 60.0 m × 250 μm× 0.25 μm) furnished
with a flame-ionization detector. A volume of 1 μL of the
sample was injected by the auto sampler at a 10:1 split ra-
tio. Helium served as the carrier gas, with a flow rate of
2.0 mL/min. Injector and column temperatures were posi-
tioned at 250°C. The initial oven temperature was 130°C
and held for 1 minute followed by a 6.5°C/min increment
increases in temperature until a temperature of 170°C was
achieved. The temperature was again increased at 2.75°C
per minute until a temperature of 215°C was reached and
maintained for 12 minutes. A final temperature of 230°C
was reached and maintained for 3 minutes. Eluted FAMEs
were identified based on comparisons to retention times
and peaks of known FAMEs contained in an external
standard (GLC 463 Standard, NU Check (Elysian, MN)).
Areas under peak curves were considered proportional to
the amount of the analyte present in the chromatograph.
Peak area measurements were obtained and individual
FAMEs within each sample were determined as a percent-
age of total fatty acids present.
Statistical analysis
Individual liver fatty acids are presented as mean percent-
age ± standard error (SE) of total fatty acids. One-way ana-
lysis of variance and Duncan’s post hoc procedures were
conducted to determine if statistically significant differ-
ences existed among the different dietary groups. Statis-
tical significance was determined at p < .05. Statistical
analyses were performed using Statistical Analysis System
(SAS) software (SAS, Inc. Cary, NC).
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